Dr. Pamela Palmer Discusses Prevention of Risk in Patient Controlled Analgesia Pump [Podcast]

Dr. Pamela Palmer discusses the risks of patient-controlled analgesia pumps and a new product that will help decrease these incidents.

In this interview, Pamela P. Palmer, MD, PhD, an anesthesiologist and pain specialist co-founder of AcelRx, has witnessed first hand the risk and harm caused by patient-controlled analgesia pumps and talks about how the new product created by AcelRX will put a stop to all theses incidents. The AcelRx is preprogrammed PCA system, which eliminates the risk of pump programming errors. The use of sufentanil NanoTabs, (an extremely small tablet which dissolves under the patients’ tongue) which eliminates the risk of IV-related analgesic gaps and the risk of IV complications.